Cargando…
ASSURED-optimized CRISPR protocol for knockout/SNP knockin in hiPSCs
CRISPR-Cas9 technology coupled with human induced pluripotent stem cells allows precise disease modeling in pluripotent cells and subsequently derived specialized cell types. Here, we present an optimized CRISPR-Cas9 pipeline, ASSURED (affordable, successful, specific, user-friendly, rapid, efficien...
Autores principales: | Ludwik, Katarzyna A., Telugu, Narasimha, Schommer, Sandra, Stachelscheid, Harald, Diecke, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382939/ https://www.ncbi.nlm.nih.gov/pubmed/37481731 http://dx.doi.org/10.1016/j.xpro.2023.102406 |
Ejemplares similares
-
Generation of hiPSC-Derived Skeletal Muscle Cells: Exploiting the Potential of Skeletal Muscle-Derived hiPSCs
por: Metzler, Eric, et al.
Publicado: (2022) -
Dopaminergic differentiation of schizophrenia hiPSCs
por: Hartley, Brigham J., et al.
Publicado: (2015) -
Genetic Cardiomyopathies: The Lesson Learned from hiPSCs
por: My, Ilaria, et al.
Publicado: (2021) -
CRISPR-Cas9 in hiPSCs: A new era in personalized treatment for Stargardt disease
por: Kuntam, Soujanya, et al.
Publicado: (2023) -
Fluorescent Gene Tagging of Transcriptionally Silent Genes in hiPSCs
por: Roberts, Brock, et al.
Publicado: (2019)